Crispr Therapeutics Ag (CRSP)

Net Margin

-895.33%

Quarterly · Period ending:

CRSP logo

CRSP Net Margin

Latest reported-895.33%
CRSP Quarterly Net Margin (0.00% → -895.33%)
High-resolution chart · PNG

CRSP net margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Net Margin — Quarterly
Period endingNet Margin
-895.3344%
-8,431.4815%
-15,117.2454%
-11,973.1159%
-23,379.9327%
-15,722.0809%
-106.6029%
-14,276.0797%
-24,450.2901%
-23,133.1349%
44.6735%
0%
-111.0571%
-53.065%
-1,842,916.6667%
-185,690.4255%
-117,616.4557%
-100,683.7079%
-1,095.0306%
-38,648.3283%
84.3394%
-56,021.2871%
-28,929.4595%
-62,458.7838%
-181,036.3636%
-44,414.6497%
39.6567%
65.3161%
-16,886.478%
-14,758.5366%
-41,382.6087%
-9,007.2824%
-3,527.5735%
-2,083.947%
0.4362%
-1,035.0649%
-622.976%
-794.4876%
729.4369%
-948.612%
-2,158.9937%
-1,773.5294%
-4,974.0891%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.